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 This retrospective study was conducted at the maternity unit of the University of Uyo Teaching 
Hospital Uyo. The aim was to determine the prevalence of HIV infection among pregnant women 
receiving antenatal care in the center. The voluntary counselling and testing register, the partner 
notification and antenatal clinic registers of all patients that booked for antenatal care between 1st July 
2005 and 31st  December 2007 were reviewed. There were 5,635 new antenatal clients during the study 
period out of which 464 were confirmed HIV positive resulting in a prevalence of 8.2%. Most of the 
patients were between 21-30 years (70.0%). About 59.4% of the patients were multiparous while 49.4% 
booked for antenatal care in the third trimester of pregnancy. HIV was diagnosed in the antenatal clinic 
in 408 (87.9%) of the patients and 182 (39.2%) received antiretroviral drugs during pregnancy. Only 
38.8% of the patients accepted to notify their partners. One hundred and eighty eight patients delivered 
in the hospital. One hundred and twenty (63.8%) had spontaneous vaginal delivery, 63 (33.5%) were 
delivered by caesarean section, 3 (1.7%) had assisted vaginal breech delivery and 2 (1.1%) had 
ventouse delivery. The high prevalence of HIV infection among women pregnant women who have 
antenatal care in our hospital is highlighted. The intensification of strategies aimed at primary prevention 
of HIV infection in the community, encouraging all pregnant women to avail themselves of orthodox 
antenatal care, and the need to emphasize the advantages of self disclosure of serostatus to partners 
during counselling sessions in the antenatal clinic are advocated. 
 




 Human immunodeficiency virus/Acquired 
immune deficiency syndrome (HIV/AIDS) 
remains the most devastating health problem 
facing the world today (Bassey et al 2007). 
Available evidence indicates that about 40 million 
people are living with the HIV virus, the vast 
majority of which reside in developing countries 
(Aniekwu, 2002). Sub-Saharan Africa which is 
home to only about 10% of the world’s population 
continues to bear the greatest burden of the 
HIV/AIDS epidemic and is reported to have 
approximately 63% of the total number of people 
living with HIV, 65% of the 4.3 million new 
infections and 72% of the 2.9 million deaths in 
2006 (National guidelines, 2007). 
 In Nigeria, since the first official report of 
HIV/AIDS’s occurrence in 1986, the disease has 
attained unprecedented proportions with a 
current national sero-prevalence rate of 4.4% 
(National guidelines, 2007). By the end of 2006, it 
was estimated that 2.99 million Nigerians were 
living with HIV, with 305,080 new infections in 
adults and 75,520 in children (Federal Ministry of 
Health, 2007). 
 African women of child bearing age have 
been shown to be particularly vulnerable to HIV 
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infection resulting in a large number of pregnant 
women in the continent infected with the virus 
(Ojukwu and Ibekwe, 2005). Human 
immunodeficiency virus infection in pregnant 
women has been shown to have several adverse 
effects not only on the mother, but also on the 
fetus. Prematurity, low birth weight, intra-uterine 
growth restriction, spontaneous abortions, fetal 
abnormality and neonatal sepsis have all been 
reported to be increased in HIV affected 
pregnancies (Ojukwu and Ibekwe, 2005, 
Segurado and Paiva, 2007). In addition, there is 
an increased risk of vertical or mother to child 
transmission (MTCT) of the virus which is 
currently estimated at 20-45% in sub-Saharan 
Africa (Asindi and Archibong, 2001). Mother to 
child transmission of HIV currently accounts for 
over 95% of infections in children and sadly, most 
reports indicate that 35-59% of African children 
infected with HIV die before their second birthday 
(Onakewhor and Airede, 2006). 
 The University of Uyo teaching hospital 
(UUTH), located in Uyo is a newly established 
teaching hospital and the only health facility that 
offers tertiary health care services to the people 
of Akwa Ibom State, in the South-South 
geopolitical zone of Nigeria. It is one of the anti-
retroviral therapy centers established by the 
federal Government and has a 63 bed maternity 
unit and an annual delivery rate of about 1,500 
deliveries. The hospital has three antenatal clinic 
sessions a week with an average clinic 
attendance of about 120 women. Antenatal care 
is provided routinely for all patients who present 
themselves for it and also for those with high risk 
pregnancies referred to the center. This study 
which is the first of its kind since the PMTCT 
program was established seeks to determine the 
prevalence of HIV infection among antenatal 
attendees, timing of HIV diagnosis and type of 
anti-retroviral treatment at the University of Uyo 
Teaching Hospital, Uyo.  
 
MATERIALS AND METHODS 
 
 This retrospective study was carried out 
at the maternity unit of UUTH Uyo. The voluntary 
counselling and testing (VCT) register, the 
partner notification and antenatal clinic registers 
of all patients that booked for antenatal care in 
the hospital between 1st July 2005 and 31st 
December 2007, were reviewed.  Information 
abstracted from patients who only registered 
once for antenatal care during the period of the 
study included their ages and parity, gestational 
age at booking, results of HIV testing, timing of 
HIV diagnosis and type of anti-retroviral 
treatment received. The registers were used for 
the study as some of the patients’ case records 
were not found and in some others, part of the 
notes were missing. The data were analysed 
using tables and percentages and the results 
obtained formed the basis of the conclusion. 




 During the study period, there were a 
total of 5,635 new antenatal clients out of which 
464 were confirmed HIV positive resulting in a 
HIV prevalence of 8.2%.  
 The patients were aged between 18 and 
42 years with the modal age group being 21-30 
years 325 (70.0%). Two hundred and sixty five 
patients (55.2%) were Para 1-4, and 49.4% of the 
patients booked for antenatal care in the third 
trimester of pregnancy (Table I). 
 All the patients accepted the HIV test. 
Four hundred and fifty five patients (98.1%) were 
recorded to have had pre-test group counselling 
while 90 patients (19.4%) who were referred from 
other health facilities or the hospital’s ARV clinic, 
were counselled individually. Four hundred and 
sixty one (99.4%) patients were recorded to have 
had post-test counselling while all the patients 
(100.0%) had infant feeding counselling.  
 Of the 464 cases, 56 (12.1%) were 
diagnosed before pregnancy and 408 (87.9%) 
were diagnosed in the ANC. A total of 182 clients 
(39.2%) had ARVs during pregnancy. Fifty-six of 
the patients (12.1%) were already receiving ARV 
drugs before pregnancy while 126 patients 
(27.2%) commenced theirs during pregnancy. 
One hundred and seventy one patients (36.9%) 
received highly active anti-retroviral therapy 
(HAART - Zidovudine, Lamivudine and 
Nevirapine) while 11 (2.4%) patients received 
Zidovudine and Lamivudine (double regimen). 
One hundred and eighty patients (38.8%) 
accepted to notify their partners. 
 One hundred and eighty women 
delivered in the hospital. One hundred and 
twenty (63.8%) had spontaneous vaginal 
delivery, 63 (33.5%) were delivered by caesarean 
section which were all for obstetric reasons, 3 
(1.7%) had assisted vaginal breech delivery and 
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Table I: Age, parity and gestational age at booking of the patients. 
N=464 
 
Variable                                                                             No (%) 
 
Age (years) 
<20                                                                                   42 (9.1)  
21-30                                                                              325 (70.0) 
31-40                                                                               91 (19.6) 
41-50                                                                                 3 (0.6) 
Not recorded                                                                      3 (0.6) 
 
Parity 
PO                                                                                                                              188 (40.5) 
P 1-4                                                                               256 (55.2) 
≥ P5                                                                                  20 (4.3) 
 
Gestational age at booking (weeks) 
                            52 (11.2) 
14-26 183 (39.4) 
27-40                                                                              229 (49.4) 
                                                                                    
  





 This study reveals the prevalence of HIV 
infection among antenatal attendees in our 
center. HIV was diagnosed in the antenatal clinic 
(ANC) in majority of the patients. This is similar to 
what obtains in other Nigerian centers (Tukur et 
al, 2007). This highlights the important role the 
ANC plays in PMTCT and also in reducing the 
incidence of HIV/AIDS particularly in communities 
like ours where the ANC may be the only setting 
where women have contact with health 
personnel. The prevalence rate reported in this 
study is higher than those reported from most 
other Nigerian centers  (Fawole et al, 2002, 
Ojukwu and Ibekwe, 2005, Ikechebelu et al, 
2006, Akani et al, 2006) and much higher than 
the rates reported from the developed world 
(Lehtouitra et al 2005). This is probably a direct 
reflection of the situation in the state as the 
recent national HIV sentinel survey revealed a 
seroprevalence of 8.0 in the state.  
 Majority of the clients were multiparous 
(55.2%) and between 21-30 years of age 
(70.0%). This is in agreement with what obtains 
in most other Nigerian centers as youths usually 
form the highest proportion of antenatal clients 
(Ikechebelu et al, 2006, Akani et al, 2006). In 
addition, the findings of previous National HIV 
sentinel surveys among ANC clients showed the 
highest age specific HIV prevalence in the 20-29 
year age group (Ekanem and Gbadegesin, 
2004). 
 It is most worrisome that only 38.8% of 
the patients accepted to notify their partners. This 
is lower than the rate reported from other 
Nigerian studies (Onakewhor and Erhabor 2006). 
Indeed data from previous Nigerian studies 
indicate that HIV positive patients do not always 
disclose their sero-status and infact may be 
ignorant of their sexual partner’s sero-status. 
Non-disclosure of sero-status to partners has 
been attributed to fear of stigmatization, physical 
violence, social ostracism and fear of accusation 
of infidelity and abandonment (Olley et al 2004, 
Onakewhor and Erhabor 2006, Akani and 
Erhabor 2006).  However, this has significant 
adverse public health consequences and remains 
a formidable challenge towards effective 
implementation of comprehensive PMTCT 
programmes (Olley et al, 2004). It jeopardizes the 
opportunity to an uninfected partner to 
adequately protect himself and an infected one 
who may not know his status to receive care.  
 All the patients in our center accepted HIV 
testing. This is because HIV testing after 
counselling is offered to all women who book for 
antenatal care with the right to opt out and there 
 
was no opt out. Majority of women in developing 
countries have been shown to accept HIV testing 
if offered particularly if HIV treatment is available 
(Ekanem and Gbadegesin, 2004, Misiri et al, 
2004). HIV counselling and testing during the 
ANC is the entry point for PMTCT and is also a 
central component of comprehensive HIV 
prevention strategies. It provides an opportunity 
for early diagnosis of HIV infection and therefore 
access to comprehensive PMTCT services which 
include ARV prophylaxis and treatment, safer 
delivery practices, safer infant feeding practices 
and prevention of opportunistic infections 
(Segurado and Paiva, 2007). It also provides an 
opportunity for referral, enables women make 
informed choices about future pregnancies and 
provides partners and other family members an 
entry point into comprehensive HIV services.  
 The safety and effectiveness of ARVs in 
reducing vertical transmission has been 
confirmed by several studies and their use is the 
most definitive ante-partum measure in PMTCT 
(Musoke and Mmiro, 2002). However, the 
number of women who received ARVs during 
pregnancy in our study was low. This is probably 
because most of the patients booked late for 
antenatal care and were therefore yet to 
complete all the baseline laboratory (lab) tests 
which include CD4 count, liver function test, renal 
function test, hepatitis B surface antigen 
estimation,  and full blood count prior to 
commencing ARVs. In addition, prior to 2006, all 
the baseline lab tests required before ARVs were 
commenced used to  cost about N12, 000 
(US$125.00) which in our resource constrained 
setting may have resulted in a barrier to some 
HIV positive pregnant women accessing ARVs. 
However, currently through the initiative of the 
Federal Government of Nigeria, with the 
assistance of foreign non-Governmental 
organisations, all the base-line lab investigations 
and also all ARV drugs are free in the hospital. 
Also with the introduction of the automated 
system, results of investigations are now 
obtained within 24 hours. Hence, the number of 
HIV positive pregnant women who would receive 
ARVs in our antenatal clinic is expected to greatly 
increase.  
 In conclusion, the prevalence of HIV 
among antenatal attendees is high but the 
number of pregnant women who assess ARVs is 
low. Thus, all health staff involved in PMTCT 
should ensure all pregnant women in the 
antenatal clinic receive ARVs. Monitoring units 
which will periodically review relevant health 
records, ensure regular supply of ARVs, and 
make appropriate recommendations to the 
hospital management is urgently needed. 
Strategies aimed at the primary prevention of HIV 
in our communities should be intensified and the 
advantages of self disclosure of sero-status to 
partners should be emphasized during 
counselling sessions in the antenatal clinic. 
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